S3 E19, Susan Nichols CEO of Propel Biosciences

Susan Nichols has spent her career bridging the gap between innovation and impact. Now, as CEO of Propel Biosciences, she’s helping startups in the cell and gene therapy space build commercial strategies that work, for patients, investors, and everyone in between.In this episode of #SheLeadsBiotech, Susan shares how her personal connection to rare disease shaped her path, what she learned transitioning from Big Pharma to biotech, and why commercialization isn’t just about revenue, it’s about responsibility.Chapters: 00:00 – Meet Susan Nichols and her personal connection to rare disease03:00 – Why cell and gene therapy felt like “sci-fi” — and what made her believe06:30 – From Big Pharma to startup life: learning to lead without the handbook10:00 – The patient as north star: what keeps her going12:00 – Leadership vs. management: how her style evolved17:00 – Managing individuals, not job titles20:00 – Why mentoring isn’t about advice — it’s about curiosity22:30 – What Propel Biosciences does, and how she helps companies get market-ready26:00 – Why good science isn’t enough without a clear commercial pathway30:00 – Breaking through the noise: messaging, clarity, and value33:00 – Advice for those entering CGT (and what not to do)🎧 Tune in to hear from a powerhouse who’s seen every side of the industry — and is now paying it forward.